EC authorises LEO Pharma Anzupgo cream for chronic hand eczema [Yahoo! Finance]
JAPAN TOBACCO UNSP/ADR (JAPAY)
NASDAQ:AMEX Investor Relations:
gungho.co.jp/en/ir
Company Research
Source: Yahoo! Finance
The cream is indicated for use in CHE patients for whom topical corticosteroids are not suitable. The approval extends to all member states of the European Union, Norway, Iceland and Liechtenstein. Both trials met their primary and all secondary endpoints. LEO Pharma CEO Christophe Bourdon stated: “We are dedicated to advancing the standard of care for those living with skin conditions, and this long-awaited milestone for Anzupgo demonstrates our purpose in practice. “This approval provides a new treatment option for patients, and we look forward to coordinating the next steps required to provide Anzupgo to those patients who need it.” The US Food and Drug Administration (FDA) has also accepted the company's new drug application seeking approval for delgocitinib cream. A topical pan-Janus kinase (JAK) inhibitor, Anzupgo works by addressing the JAK-STAT signalling pathway implicated in CHE's pathogenesis. LEO Pharma holds the sole rights for the development and commercia
Show less
Read more
Impact Snapshot
Event Time:
JAPAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAPAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAPAY alerts
High impacting JAPAN TOBACCO UNSP/ADR news events
Weekly update
A roundup of the hottest topics
JAPAY
News
- LEO Pharma's Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland [Yahoo! Finance]Yahoo! Finance
- Japan Tobacco Inc (JAPAF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- Proposed $32.5B tobacco deal not 'doomed to fail,' judge says in ruling [Yahoo! Finance Canada]Yahoo! Finance Canada
- Opinion: Take Big Tobacco's money and help people quit smoking [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Tobacco company opposes proposed $32.5B settlement with provinces, smokers: court doc [Financial Post (Toronto, Ontario, Canada)]Financial Post